Metraipolis › archive › dc_581b80102bc3

Early divergence of treatment response trajectories to adalimumab or its biosimilar in active ankylosing spondylitis: consensus clustering analysis of a… — Europe PMC PMID:42416060

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42416060
DOI
10.3389/fimmu.2026.1804751
License (as archived)
solo-consultazione
Archived
2026-10-19T05:51:02.890Z
SHA-256 of the archived text
af1a60655b10295701d876989b770f9758a8a695a0600291d458c2f21eec05dc
Stable URL of this page
https://metraipolis.com/documento/dc_581b80102bc3

How to cite

Early divergence of treatment response trajectories to adalimumab or its biosimilar in active ankylosing spondylitis: consensus clustering analysis of a… — Europe PMC PMID:42416060 — Europe PMC (en), https://europepmc.org/article/MED/42416060 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_581b80102bc3 (Metraipolis archive dc_581b80102bc3, sha256 af1a60655b10295701d876989b770f9758a8a695a0600291d458c2f21eec05dc)
BibTeX
@misc{dc581b80102bc3,
  title = {Early divergence of treatment response trajectories to adalimumab or its biosimilar in active ankylosing spondylitis: consensus clustering analysis of a… — Europe PMC PMID:42416060},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42416060},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_581b80102bc3; sha256 af1a60655b10295701d876989b770f9758a8a695a0600291d458c2f21eec05dc},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42416060. Agents can read the archived copy with the MCP tool read_document.